Page 934 - TNFlipTest

OP44 Ophthalmology References Toronto Notes 2019 References
ACCORD Study Group; ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. NEJM 2010;363:233-244.
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436.
Anderson DR, Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 2003;14:6-90.
Atlas of ophthalmology. Available from: www.atlasophthalmology.com/atlas/frontpage.jsf.
Bhagat N, Nagori S, Zarbin M. Post-traumatic Infectious Endophthalmitis. Surv Ophthalmol 2011;56:214-51.
Bradford C. Basic ophthalmology for medical students and primary care residents, 7th ed. San Francisco: American Academy of Ophthalmology, 1999.
Buitendijk GHS, Schauwvlieghe AME, Vingerling JR. et al. Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial. Am J Ophthalmol 2018; 187:130-137. CATT Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. NEJM 2011;364:1897-1908.
Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011;118:609-614.
Friedman N, Pineda R, Kaiser P. The Massachusetts eye and ear infirmary illustrated manual of ophthalmology. Toronto: WB Saunders, 1998.
Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev 2015;8:CD001430.
Glanville J, Patterson J, McCool R, et al. Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review. BMC Ophthalmol 2014;14:17.
Haller JA, Bandello F, Belfort R Jr, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macula edema due to retinal vein occlusion. Ophthal 2010;117:1134-1146.
Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Opthalmol 2002;120:1268-1279.
Kanski JJ. Clinical Ophthalmology: A systematic approach, 6th ed. Oxford: Butterworth-Heinemann, 2007.
Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthal 2001;108:1943-1953.
Lim CH, Turner A, Lim BX. Patching for corneal abrasion. Cochrane Database Syst Rev 2016;7:CD004764.
Maguire AM, High KA, Auricchio A, et al. Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009;374:1597-1605.
Moore DL, MacDonald NE, Canadian Paediatric Society, et al. Preventing ophthalmia neonatorum. Paediatr Child Health 2015;20:93-96.
Pushker N, Tejwani LK, Bajaj MS, et al. Role of oral corticosteroids in orbital cellulitis. Am J Ophthalmol 2013;156:178-183.
Rayapudi S, Schwartz SG, Wang X, et al. Vitamin A and fish oils for retinitis pigmentosa. Cochrane Database Syst Rev 2013;12:CD008428.
Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev 2016;1:CD009734.
Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2012;9:CD001211.
Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002;287:92-101.
Solomon SD, Lindsley KB, Krzystolik MG, et al. Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review. Ophthalmology 2016; 123:70-77. Stein R, Stein H. Management of ocular emergencies, 4th ed. Montreal: Mediconcept, 2006.
Tasman W, Jaegar EA. Duane’s ophthalmology, 2011 ed. Philadelphia: Lippincott Wiliams & Wilkins, 2010.
University of Michigan Kellogg Eye Centre. Available from: www.kellogg.umich.edu/theeyeshaveit/index.html.
Vass C, Hirn C, Sycha T, et al. Medical interventions for primary open-angle glaucoma and ocular hypertension. Cochrane Database Syst Rev 2007;4:CD003167.
Vedula SS, Krzystolik MG. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2008;2:CD005139.
Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: 2 year result from a comparative effectiveness randomized clinical trial. Ophthal 2016;123:1351-1359.
Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 2010;12:CD002898.
Wilson FM. Practical ophthalmology: a manual for beginning residents, 4th ed. American Academy of Ophthalmology, 2005.
Wong AM. New concepts concerning the neural mechanisms of amblyopia and their clinical implications. Can J Opthalmol 2012;47:399-409.